| Total (n = 43) | Tai Chi group (n = 29) | Control group (n = 14) | P |
---|---|---|---|---|
Demographic, mean ± SD | ||||
 Age, years | 63.6 ± 5.53 | 64.0 ± 5.4 | 62.7 ± 5.9 | 0.469 |
Anthropometric, mean ± SD | ||||
 Height, cm | 153.8 ± 5.6 | 154.2 ± 5.7 | 153.0 ± 5.6 | 0.506 |
 Weight, kg | 54.0 ± 7.8 | 53.7 ± 7.6 | 54.6 ± 8.4 | 0.725 |
 BMI, kg/m2 | 22.8 ± 2.9 | 22.5 ± 2.7 | 23.4 ± 3.2 | 0.388 |
 Waist circumference, cm | 79.3 ± 8.4 | 78.3 ± 8.5 | 81.4 ± 8.1 | 0.259 |
 Waist-hip ratio | 0.86 ± 0.53 | 0.85 ± 0.01 | 0.87 ± 0.05 | 0.142 |
Medical history, n (%) | ||||
 Hypertension | 23 (53.5) | 15 (51.7) | 8 (57.1) | 0.739 |
 Diabetes mellitus | 3 (7.0) | 1 (3.4) | 2 (14.3) | 0.191 |
 Dyslipidemia | 20 (46.5) | 12 (41.4) | 8 (57.1) | 0.331 |
 Coronary artery disease | 2 (4.6) | 1 (3.4) | 1 (7.1) | 0.590 |
 Cerebrovascular disease | 4 (9.3) | 2 (6.9) | 2 (14.3) | 0.434 |
 Smoking | 6 (13.9) | 2 (6.9) | 4 (28.6) | 0.133 |
RA medication, n (%) | ||||
 Methotrexate | 36 (83.7) | 24 (82.8) | 12 (85.7) | 0.806 |
 Hydroxychloroquine | 17 (39.5) | 11 (37.9) | 6 (42.9) | 0.757 |
 Sulfasalazine | 5 (11.6) | 3 (10.3) | 2 (14.3) | 0.706 |
 Leflunomide | 11 (25.6) | 7 (24.1) | 4 (28.6) | 0.755 |
 Glucocorticoids | 31 (72.1) | 21 (72.4) | 10 (71.4) | 0.946 |
 Dosage, median, mg/day | 2.5 | 2.5 | 2.5 | 0.168 |
RA characteristics, mean ± SD | ||||
 Disease duration, years | 12.0 ± 9.2 | 10.3 ± 9.4 | 15.4 ± 8.0 | 0.092 |
 anti-CCP, n (%) | 38 (88.4) | 24 (82.8) | 14 (100) | 0.307 |
 Swollen joint count, 0–69 joints | 1.2 ± 2.4 | 1.5 ± 2.9 | 0.6 ± 0.9 | 0.237 |
 Tender joint count, 0–69 joints | 3.6 ± 4.7 | 4.5 ± 5.5 | 1.6 ± 1.5 | 0.012 |
 DAS-28-ESR | 3.7 ± 1.0 | 3.8 ± 1.1 | 3.5 ± 0.6 | 0.229 |
 RAPID3 | 9.4 ± 4.5 | 9.4 ± 4.7 | 9.2 ± 4.0 | 0.895 |
 HAQ | 0.54 ± 0.46 | 0.63 ± 0.50 | 0.35 ± 0.29 | 0.024 |
 ESR | 31.7 ± 21.9 | 31.4 ± 22.7 | 32.2 ± 21.0 | 0.908 |
 CRP | 0.44 ± 0.44 | 0.48 ± 0.49 | 0.36 ± 0.34 | 0.384 |
CVD, mean ± SD | ||||
 Systolic BP, mm Hg | 130.5 ± 11.6 | 129.2 ± 12.1 | 133.1 ± 10.5 | 0.313 |
 Diastolic BP, mm Hg | 77.6 ± 5.2 | 77.0 ± 4.8 | 78.7 ± 6.0 | 0.331 |
 Heart rate | 72.0 ± 6.1 | 72.5 ± 5.4 | 71.0 ± 7.5 | 0.473 |
 Total cholesterol, mg/dl | 184.6 ± 35.8 | 187.3 ± 36.1 | 179.0 ± 35.6 | 0.480 |
 Triglycerides, mg/dl | 112.2 ± 47.4 | 108.7 ± 36.6 | 122.14 ± 54.3 | 0.343 |
 HDL, mg/dl | 61.6 ± 12.0 | 63.9 ± 12.1 | 56.8 ± 10.5 | 0.070 |
 LDL, mg/dl | 97.9 ± 31.1 | 96.6 ± 31.4 | 100.7 ± 31.7 | 0.689 |
 Fasting glucose, mg/dl | 91.5 ± 11.1 | 89.8 ± 9.3 | 95.1 ± 13.9 | 0.141 |
 Creatinine, mg/dl | 0.74 ± 0.12 | 0.72 ± 0.12 | 0.76 ± 0.11 | 0.300 |
Atherosclerosis, mean ± SD | ||||
 cIMT, mm | 0.68 ± 0.13 | 0.69 ± 0.13 | 0.66 ± 0.13 | 0.596 |
 FMD, % | 6.00 ± 2.06 | 5.85 ± 2.05 | 6.31 ± 2.12 | 0.494 |
 baPWV, cm/s | 1708.8 ± 303.3 | 1693.7 ± 348.3 | 1740.3 ± 185.3 | 0.643 |